Williams Olughu
Williams Olughu, Ph.D., is a senior principal scientist at Ipsen Biopharmaceuticals Ltd. in the United Kingdom, where he serves as the CMC technical lead for one of the company’s antibody-drug conjugate programs. He is a Royal Academy of Engineering visiting professor at Loughborough University and an editorial board member for the World Journal of Microbiology and Biotechnology and the Journal of Chemical Technology and Biotechnology.
ARTICLES BY WILLIAMS OLUGHU
-
![Vial of Covid-19 Coronavirus Vaccine-GettyImages-1319914581]( "Managing Extractables And Leachables In HPAPI Manufacturing")
7/10/2025These contaminants can compromise the quality, stability, and safety of a drug product, and regulatory bodies mandate assessment to protect patients.
-
![Young Researchers in Laboratory-GettyImages-1278777784]( "Challenges And Opportunities Of Outsourcing Biopharma Development")
2/19/2025Oversight, knowledge management, and operational/compliance risk make up the three key challenge classifications to consider when approaching a new outsourcing agreement.
-
![GettyImages-1434121129]( "Which Of These 6 Outsourcing Models Best Suits Your Program?")
2/19/2025Outsourcing used to be a cost-cutting exercise. Now drug developers use it to add expertise and manufacturing efficiencies to their production teams.
